Skip to main content
SpringerLink
Log in

Novel Infectious Diseases and Emerging Gram-Positive Multi-Resistant Pathogens in Hospital and Community Acquired Infections

  • Chapter
  • First Online:
Book cover Antimicrobials

Abstract

Gram-positive pathogens are a major cause of healthcare-associated and community-acquired bacterial infections. Staphylococci (mostly Staphylococcus aureus but also coagulase-negative staphylococci), enterococci, streptococci, and Clostridium difficile are the most important species of clinical interest. Antibiotic resistance issues are common among Gram-positive pathogens, especially among staphylococci and enterococci. Methicillin-resistant Staphylococcus aureus (MRSA) and glycopeptide-resistant enterococci (GRE) are paradigms for difficult-to-treat multi-resistant pathogen capable of global-scale diffusion, with remarkable impact on morbidity, mortality, and healthcare-associated costs. MRSA, in particular, is the most relevant Gram-positive multi-resistant pathogen in terms of diffusion and overall clinical impact, being a leading cause for healthcare-associated infections worldwide, as well as an emerging cause of community-acquired infections that are often associated with novel MRSA strains. Resistance to anti-MRSA and anti-VRE drugs remains uncommon or exceptional among the respective species. However, invasive infections caused by MRSA strains resistant to glycopeptides, linezolid, or daptomycin, and by VRE strains resistant to linezolid or daptomycin have increasingly been reported, especially after prolonged drug exposure, and a transferable resistance mechanism to linezolid and other anti-ribosomal agents has recently emerged among staphylococci and enterococci. This evolving scenario underscores the need for continuing efforts aimed at surveillance and control of infections caused by multi-resistant Gram-positives, and at the discovery and development of new drugs active against these pathogens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Dabiri H, Sedaght H (2008) Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract 17:432–434

    Article  PubMed  Google Scholar 

  • Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, Diaz L, Tran TT, Rincon S, Barbu EM, Reyes J, Roh JH, Lobos E, Sodergren E, Pasqualini R, Arap W, Quinn JP, Shamoo Y, Murray BE, Weinstock GM (2011) Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 365:892–900

    Article  PubMed  CAS  Google Scholar 

  • Arias CA, Mendes RE, Stilwell MG, Jones RN, Murray BE (2012) Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections. Clin Infect Dis 54(Suppl 3):S233–S238

    Article  PubMed  CAS  Google Scholar 

  • Auckland C, Teare L, Cooke F, Kaufmann ME, Warner M, Jones G, Bamford K, Ayles H, Johnson AP (2002) Linezolid-resistant enterococci: report of the first isolates in the United Kingdom. J Antimicrob Chemother 50:743–746

    Article  PubMed  CAS  Google Scholar 

  • Babakhani F, Gomez A, Robert N, Sears P (2011) Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile. J Med Microbiol 60:1213–1217

    Article  PubMed  CAS  Google Scholar 

  • Bae IG, Federspiel JJ, Miro JM, Woods CW, Park L, Rybak MJ, Rude TH, Bradley S, Bukovski S, de la Maria CG, Kanj SS, Korman TM, Marco F, Murdoch DR, Plesiat P, Rodriguez-Creixems M, Reinbott P, Steed L, Tattevin P, Tripodi MF, Newton KL, Corey GR, Fowler VG (2009) Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. J Infect Dis 200:1355–1366

    Article  PubMed  CAS  Google Scholar 

  • Baines SD, O’Connor R, Freeman J, Fawley WN, Harmanus C, Mastrantonio P, Kuijper EJ, Wilcox MH (2008) Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother 62:1046–1052

    Article  PubMed  CAS  Google Scholar 

  • Bartley J (2002) First case of VRSA identified in Michigan. Infect Control Hosp Epidemiol 23:480

    PubMed  Google Scholar 

  • Benefield RJ, Hinde GK, Abolnik IZ (2012) Osteomyelitits due to linezolid-resistant Staphylococcus epidermidis. Clin Infect Dis 54:1216–1217

    Article  PubMed  Google Scholar 

  • Berenger R, Bourdon N, Auzou M, Leclercq R, Cattoir V (2011) In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008. Med Mal Infect 41:405–409

    Article  PubMed  CAS  Google Scholar 

  • Besier S, Ludwig A, Zander J, Brade V, Wichelhaus TA (2008) Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob Agents Chemother 52:1570–1572

    Article  PubMed  CAS  Google Scholar 

  • Billstrom H, Lund B, Sullivan A, Nord CE (2008) Virulence and antimicrobial resistance in clinical Enterococcus faecium. Int J Antimicrob Agents 32:374–377

    Article  PubMed  CAS  Google Scholar 

  • Bongiorno D, Campanile F, Mongelli G, Baldi MT, Provenzani R, Reali S, Lo RC, Santagati M, Stefani S (2010) DNA methylase modifications and other linezolid resistance mutations in coagulase-negative staphylococci in Italy. J Antimicrob Chemother 65:2336–2340

    Article  PubMed  CAS  Google Scholar 

  • Bonilla H, Huband MD, Seidel J, Schmidt H, Lescoe M, McCurdy SP, Lemmon MM, Brennan LA, Tait-Kamradt A, Puzniak L, Quinn JP (2010) Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain. Clin Infect Dis 51:796–800

    Article  PubMed  Google Scholar 

  • Boucher HW, Corey GR (2008) Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46(Suppl 5):S344–S349

    Article  PubMed  Google Scholar 

  • Cafiso V, Bertuccio T, Spina D, Purrello S, Campanile F, Di PC, Purrello M, Stefani S (2012) Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains. PLoS ONE 7:e29573

    Article  PubMed  CAS  Google Scholar 

  • Campanile F, Bongiorno D, Falcone M, Vailati F, Pasticci MB, Perez M, Raglio A, Rumpianesi F, Scuderi C, Suter F, Venditti M, Venturelli C, Ravasio V, Codeluppi M, Stefani S (2012) Changing Italian nosocomial-community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis. Eur J Clin Microbiol Infect Dis 31:739–745

    Article  PubMed  CAS  Google Scholar 

  • Contreras GA, DiazGranados CA, Cortes L, Reyes J, Vanegas S, Panesso D, Rincon S, Diaz L, Prada G, Murray BE, Arias CA (2008) Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci. J Hosp Infect 70:346–352

    Article  PubMed  CAS  Google Scholar 

  • Crombe F, Willems G, Dispas M, Hallin M, Denis O, Suetens C, Gordts B, Struelens M, Butaye P (2012) Prevalence and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus among pigs in Belgium. Microb Drug Resist 18:125–131

    Article  PubMed  CAS  Google Scholar 

  • Curry SR, Marsh JW, Shutt KA, Muto CA, O’Leary MM, Saul MI, Pasculle AW, Harrison LH (2009) High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital. Clin Infect Dis 48(4):425–429

    Google Scholar 

  • Darabi A, Hocquet D, Dowzicky MJ (2010) Antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2004 and 2008 as part of the Tigecycline Evaluation and Surveillance Trial. Diagn Microbiol Infect Dis 67:78–86

    Article  PubMed  CAS  Google Scholar 

  • David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23:616–687

    Article  PubMed  CAS  Google Scholar 

  • de Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, Icket C, Kalenic S, Horvatic J, Seifert H, Kaasch AJ, Paniara O, Argyropoulou A, Bompola M, Smyth E, Skally M, Raglio A, Dumpis U, Kelmere AM, Borg M, Xuereb D, Ghita MC, Noble M, Kolman J, Grabljevec S, Turner D, Lansbury L, Grundmann H; BURDEN Study Group (2011) Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 55:1598–1605

    Article  CAS  Google Scholar 

  • DeLeo FR, Chambers HF (2009) Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest 119:2464–2474

    Article  PubMed  CAS  Google Scholar 

  • DeLeo FR, Otto M, Kreiswirth BN, Chambers HF (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375:1557–1568

    Article  PubMed  Google Scholar 

  • Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN (2007) Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 58(2):163–170

    Google Scholar 

  • Diaz L, Kiratisin P, Mendes RE, Panesso D, Singh KV, Arias CA (2012) Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis. Antimicrob Agents Chemother 56:3917–3922

    Article  PubMed  CAS  Google Scholar 

  • EARS-Net (2010) Annual report of the European Antimicrobial Resistance Surveillance Network. European Centre for Disease Prevention and Control. http://www.ecdc.europa.eu/en/publications/Publications/1111_SUR_AMR_data.pdf.pdf

  • Endimiani A, Blackford M, Dasenbrook EC, Reed MD, Bajaksouszian S, Hujer AM, Rudin SD, Hujer KM, Perreten V, Rice LB, Jacobs MR, Konstan MW, Bonomo RA (2011) Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio. Antimicrob Agents Chemother 55:1684–1692

    Article  PubMed  CAS  Google Scholar 

  • Enoch DA, Bygott JM, Daly ML, Karas JA (2007) Daptomycin. J Infect 55:205–213

    Article  PubMed  Google Scholar 

  • Flamm RK, Farrell DJ, Mendes RE, Ross JE, Sader HS, Jones RN (2012) LEADER Surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers). Diagn Microbiol Infect Dis. doi:10.1016/j.diagmicrobio.2012.05.012

    Google Scholar 

  • Freitas AR, Novais C, Correia R, Monteiro M, Coque TM, Peixe L (2011) Non-susceptibility to tigecycline in enterococci from hospitalised patients, food products and community sources. Int J Antimicrob Agents 38:174–176

    Article  PubMed  CAS  Google Scholar 

  • Fuda C, Suvorov M, Vakulenko SB, Mobashery S (2004) The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J Biol Chem 279:40802–40806

    Article  PubMed  CAS  Google Scholar 

  • Gardete S, Aires-De-Sousa M, Faustino A, Ludovice AM, de Lencastre H (2008) Identification of the first vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolate from a hospital in Portugal. Microb Drug Resist 14:1–6

    Google Scholar 

  • Gardete S, Kim C, Hartmann BM, Mwangi M, Roux CM, Dunman PM, Chambers HF, Tomasz A (2012) Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog 8:e1002505

    Article  PubMed  CAS  Google Scholar 

  • Goldstein EJ, Citron DM, Sears P, Babakhani F, Sambol SP, Gerding DN (2011) Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infection. Antimicrob Agents Chemother 55:5194–5199

    Article  PubMed  CAS  Google Scholar 

  • Gonzales RD, Schreckenberger PC, Graham MB, Kelkar S, DenBesten K, Quinn JP (2001) Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357:1179

    Article  PubMed  CAS  Google Scholar 

  • Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, Friedrich AW (2010) Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 7:e1000215

    Article  PubMed  Google Scholar 

  • Hageman JC, Patel J, Franklin P, Miscavish K, McDougal L, Lonsway D, Khan FN (2008) Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus. Diagn Microbiol Infect Dis 62:440–442

    Article  PubMed  CAS  Google Scholar 

  • Hait H, Arbeit R, Molnar D, Noel GJ, Tanaka SK (2011) In a phase 2 complicated skin and soft tissue infections (cSSTI) trial outcomes assessed early in the course of therapy were consistent with outcomes assessed 10–17 days after completing therapy for patients treated with either omadacycline (OMC; PTK796) or linezolid. 21st European congress of clinical microbiology and infectiousdiseases (ECCMID)/27th international congress of chemotherapy (ICC)

    Google Scholar 

  • Hecht DW, Galang MA, Sambol SP, Osmolski JR, Johnson S, Gerding DN (2007) In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother 51:2716–2719

    Article  PubMed  CAS  Google Scholar 

  • Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29:996–1011

    Article  PubMed  Google Scholar 

  • Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135–136

    Article  PubMed  CAS  Google Scholar 

  • Hope R, Mushtaq S, James D, Pllana T, Warner M, Livermore DM (2010) Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK. J Antimicrob Chemother 65:2602–2609

    Article  PubMed  CAS  Google Scholar 

  • Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 23:99–139

    Article  PubMed  CAS  Google Scholar 

  • Howe RA, Monk A, Wootton M, Walsh TR, Enright MC (2004) Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis 10:855–857

    Article  PubMed  CAS  Google Scholar 

  • Huang H, Weintraub A, Fang H, Nord CE (2009) Antimicrobial resistance in Clostridium difficile. Int J Antimicrob Agents 34:516–522

    Article  PubMed  CAS  Google Scholar 

  • Itani KM, Dryden MS, Bhattacharyya H, Kunkel MJ, Baruch AM, Weigelt JA (2010) Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg 199:804–816

    Article  PubMed  CAS  Google Scholar 

  • Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, Duckworth G (2012) Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 67:802–809

    Article  PubMed  CAS  Google Scholar 

  • Jones RN (2010) Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 51(Suppl 1):S81–S87

    Google Scholar 

  • Jones RN, Kohno S, Ono Y, Ross JE, Yanagihara K (2009) ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries. Diagn Microbiol Infect Dis 64:191–201

    Article  PubMed  CAS  Google Scholar 

  • Kelesidis T, Humphries R, Uslan DZ, Pegues DA (2011) Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis 52:228–234

    Article  PubMed  Google Scholar 

  • Kelesidis T, Humphries R, Uslan DZ, Pegues D (2012) De novo daptomycin-nonsusceptible enterococcal infections. Emerg Infect Dis 18:674–676

    Article  PubMed  Google Scholar 

  • Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S (2011) Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 66:1594–1599

    Article  PubMed  CAS  Google Scholar 

  • Kihara R, Yanagihara K, Morinaga Y, Araki N, Nakamura S, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Tsukamoto K, Kamihira S, Kohno S (2008) Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 52:2163–2168

    Article  PubMed  CAS  Google Scholar 

  • Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763–1771

    Article  PubMed  CAS  Google Scholar 

  • Kock R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro TA, Witte W, Friedrich AW (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15:19688

    PubMed  CAS  Google Scholar 

  • Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128:3854–3862

    Article  PubMed  Google Scholar 

  • Kos VN, Desjardins CA, Griggs A, Cerqueira G, Van TA, Holden MT, Godfrey P, Palmer KL, Bodi K, Mongodin EF, Wortman J, Feldgarden M, Lawley T, Gill SR, Haas BJ, Birren B, Gilmore MS (2012) Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with methicillin-resistant S. aureus hospital-acquired infection in the United States. MBio. doi:10.1128/mBio.00112-12

  • Kosowska-Shick K, Clark C, Pankuch GA, McGhee P, Dewasse B, Beachel L, Appelbaum PC (2009) Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies. Antimicrob Agents Chemother 53:4217–4224

    Article  PubMed  CAS  Google Scholar 

  • Leavis H, Top J, Shankar N, Borgen K, Bonten M, van Embden J, Willems RJ (2004) A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J Bacteriol 186:672–682

    Google Scholar 

  • Lebreton F, Depardieu F, Bourdon N, Fines-Guyon M, Berger P, Camiade S, Leclercq R, Courvalin P, Cattoir V (2011) D-Ala-D-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 55:4606–4612

    Article  PubMed  CAS  Google Scholar 

  • Lesho EP, Wortmann GW, Craft D, Moran KA (2006) De novo daptomycin nonsusceptibility in a clinical isolate. J Clin Microbiol 44:673

    Article  PubMed  Google Scholar 

  • Lessa FC, Gould CV, McDonald LC (2012) Current status of Clostridium difficile infection epidemiology. Clin Infect Dis 55(Suppl 2):S65–S70

    Article  PubMed  CAS  Google Scholar 

  • Li CR, Li Y, Li GQ, Yang XY, Zhang WX, Lou RH, Liu JF, Yuan M, Huang P, Cen S, Yu LY, Zhao LX, Jiang JD, You XF (2010) In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone. J Antimicrob Chemother 65:2411–2415

    Article  PubMed  CAS  Google Scholar 

  • Li HT, Zhang TT, Huang J, Zhou YQ, Zhu JX, Wu BQ (2011) Factors associated with the outcome of life-threatening necrotizing pneumonia due to community-acquired Staphylococcus aureus in adult and adolescent patients. Respiration 81:448–460

    Article  PubMed  Google Scholar 

  • Linares J, Ardanuy C, Pallares R, Fenoll A (2010) Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 16:402–410

    Article  PubMed  CAS  Google Scholar 

  • Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak J, Talan DA, Chambers HF (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285–292

    Article  PubMed  Google Scholar 

  • Long KS, Vester B (2012) Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob Agents Chemother 56:603–612

    Article  PubMed  CAS  Google Scholar 

  • Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B (2006) The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 50:2500–2505

    Article  PubMed  CAS  Google Scholar 

  • Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364:422–431

    Article  PubMed  CAS  Google Scholar 

  • Malani PN, Kauffman CA, Zervos MJ (2002) Enterococcal disesase, epidemiology, and treatment. In: Gilmore MS, Clewell DB, Courvalinv P, Dunny GM, Murray BE (eds) The enterococci: pathogenesis, molecular biology, and antibiotic resistance. ASM Press, Washington D.C

    Google Scholar 

  • Mammina C, Cala C, Plano MR, Bonura C, Vella A, Monastero R, Palma DM (2010) Ventilator-associated pneumonia and MRSA ST398, Italy. Emerg Infect Dis 16:730–731

    Article  PubMed  Google Scholar 

  • Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG (2007) Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 13:236–242

    Article  PubMed  Google Scholar 

  • McCallum N, Karauzum H, Getzmann R, Bischoff M, Majcherczyk P, Berger-Bachi B, Landmann R (2006) In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance. Antimicrob Agents Chemother 50:2352–2360

    Article  PubMed  CAS  Google Scholar 

  • McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, Johnson S, Gerding DN (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353:2433–2441

    Article  PubMed  CAS  Google Scholar 

  • Mendes RE, Tsakris A, Sader HS, Jones RN, Biek D, McGhee P, Appelbaum PC, Kosowska-Shick K (2012) Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline. J Antimicrob Chemother 67:1321–1324

    Article  PubMed  CAS  Google Scholar 

  • Miller BA, Chen LF, Sexton DJ, Anderson DJ (2011) Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 32:387–390

    Article  PubMed  Google Scholar 

  • Mishra NN, Yang SJ, Sawa A, Rubio A, Nast CC, Yeaman MR, Bayer AS (2009) Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:2312–2318

    Article  PubMed  CAS  Google Scholar 

  • Monecke S, Coombs G, Shore AC, Coleman DC, Akpaka P, Borg M, Chow H, Ip M, Jatzwauk L, Jonas D, Kadlec K, Kearns A, Laurent F, O’Brien FG, Pearson J, Ruppelt A, Schwarz S, Scicluna E, Slickers P, Tan HL, Weber S, Ehricht R (2011) A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS ONE 6:e17936

    Article  PubMed  CAS  Google Scholar 

  • Morales G, Picazo JJ, Baos E, Candel FJ, Arribi A, Pelaez B, Andrade R, De la Torre MA, Fereres J, Sanchez-Garcia M (2010) Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis 50:821–825

    Article  PubMed  CAS  Google Scholar 

  • Munita JM, Panesso D, Diaz L, Tran TT, Reyes J, Wanger A, Murray BE, Arias CA (2012) Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints. Antimicrob Agents Chemother 56:4354–4359

    Article  PubMed  CAS  Google Scholar 

  • Neoh HM, Cui L, Yuzawa H, Takeuchi F, Matsuo M, Hiramatsu K (2008) Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance. Antimicrob Agents Chemother 52:45–53

    Article  PubMed  CAS  Google Scholar 

  • Ntokou E, Stathopoulos C, Kristo I, Dimitroulia E, Labrou M, Vasdeki A, Makris D, Zakynthinos E, Tsakris A, Pournaras S (2012) Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother 67:1819–1823

    Article  PubMed  CAS  Google Scholar 

  • O’Connor JR, Galang MA, Sambol SP, Hecht DW, Vedantam G, Gerding DN, Johnson S (2008) Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile. Antimicrob Agents Chemother 52:2813–2817

    Article  PubMed  CAS  Google Scholar 

  • Otter JA, French GL (2010) Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 10:227–239

    Article  PubMed  Google Scholar 

  • Otter JA, French GL (2011) Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect 79:189–193

    Article  PubMed  CAS  Google Scholar 

  • Perichon B, Courvalin P (2009) VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:4580–4587

    Article  PubMed  CAS  Google Scholar 

  • Porrero MC, Wassenaar TM, Gomez-Barrero S, Garcia M, Barcena C, Alvarez J, Saez-Llorente JL, Fernandez-Garayzabal JF, Moreno MA, Dominguez L (2012) Detection of methicillin-resistant Staphylococcus aureus in Iberian pigs. Lett Appl Microbiol 54:280–285

    Article  PubMed  CAS  Google Scholar 

  • Prystowsky J, Siddiqui F, Chosay J, Shinabarger DL, Millichap J, Peterson LR, Noskin GA (2001) Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 45:2154–2156

    Article  PubMed  CAS  Google Scholar 

  • Rahim S, Pillai SK, Gold HS, Venkataraman L, Inglima K, Press RA (2003) Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin Infect Dis 36:E146–E148

    Article  PubMed  Google Scholar 

  • Reynolds PE, Courvalin P (2005) Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine. Antimicrob Agents Chemother 49:21–25

    Article  PubMed  CAS  Google Scholar 

  • Rolo J, Miragaia M, Turlej-Rogacka A, Empel J, Bouchami O, Faria NA, Tavares A, Hryniewicz W, Fluit AC, de Lencastre H (2012) High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study. PLoS One 7:e34768

    Google Scholar 

  • Ross JE, Farrell DJ, Mendes RE, Sader HS, Jones RN (2011) Eight-year (2002–2009) summary of the linezolid (Zyvox(R) annual appraisal of potency and spectrum; ZAAPS) program in European countries. J Chemother 23:71–76

    PubMed  CAS  Google Scholar 

  • Rubin DT, Sohi S, Glathar M, Thomas T, Yadron N, Surma BL (2011) Rifaximin is effective for the treatment of Clostridium difficile-associated diarrhea: results of an open-label pilot study. Gastroenterol Res Pract 2011:106978

    PubMed  Google Scholar 

  • Saager B, Rohde H, Timmerbeil BS, Franke G, Pothmann W, Dahlke J, Scherpe S, Sobottka I, Heisig P, Horstkotte MA (2008) Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using pyrosequencing. Eur J Clin Microbiol Infect Dis 27:873–878

    Article  PubMed  CAS  Google Scholar 

  • Saha B, Singh AK, Ghosh A, Bal M (2008) Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol 57:72–79

    Article  PubMed  CAS  Google Scholar 

  • Sanchez-Garcia M, De la Torre MA, Morales G, Pelaez B, Tolon MJ, Domingo S, Candel FJ, Andrade R, Arribi A, Garcia N, Martinez SF, Fereres J, Picazo J (2010) Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 303:2260–2264

    Article  PubMed  CAS  Google Scholar 

  • Schaumburg F, Kock R, Mellmann A, Richter L, Hasenberg F, Kriegeskorte A, Friedrich AW, Gatermann S, Peters G, von Eiff C, Becker K (2012) Population dynamics among methicillin resistant Staphylococcus aureus in Germany during a 6-year period. J Clin Microbiol. doi:10.1128/JCM.01174-12

  • Schulte B, Heininger A, Autenrieth IB, Wolz C (2008) Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium. Epidemiol Infect 136:1131–1133

    Article  PubMed  CAS  Google Scholar 

  • Shah D, Dang MD, Hasbun R, Koo HL, Jiang ZD, DuPont HL, Garey KW (2010) Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther 8:555–564

    Article  PubMed  CAS  Google Scholar 

  • Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46:668–674

    Article  PubMed  CAS  Google Scholar 

  • Skov R, Christiansen K, Dancer SJ, Daum RS, Dryden M, Huang YC, Lowy FD (2012) Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA). Int J Antimicrob Agents 39:193–200

    Article  PubMed  CAS  Google Scholar 

  • Soavi L, Stellini R, Signorini L, Antonini B, Pedroni P, Zanetti L, Milanesi B, Pantosti A, Matteelli A, Pan A, Carosi G (2010) Methicillin-resistant Staphylococcus aureus ST398, Italy. Emerg Infect Dis 16:346–348

    Article  PubMed  Google Scholar 

  • Song JH, Hsueh PR, Chung DR, Ko KS, Kang CI, Peck KR, Yeom JS, Kim SW, Chang HH, Kim YS, Jung SI, Son JS, So TM, Lalitha MK, Yang Y, Huang SG, Wang H, Lu Q, Carlos CC, Perera JA, Chiu CH, Liu JW, Chongthaleong A, Thamlikitkul V, Van PH (2011) Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother 66:1061–1069

    Article  PubMed  CAS  Google Scholar 

  • Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H, Mackenzie FM (2012) Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents 39:273–282

    Article  PubMed  CAS  Google Scholar 

  • Sujatha S, Praharaj I (2012) Glycopeptide resistance in Gram-positive cocci: a review. Interdiscip Perspect Infect Dis 2012:781679

    PubMed  CAS  Google Scholar 

  • Swoboda S, Fritz S, Martignoni ME, Feldhues RA, Hoppe-Tichy T, Buchler MW, Geiss HK (2005) Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report. J Antimicrob Chemother 56:787–789

    Article  PubMed  CAS  Google Scholar 

  • Tenover FC, Tickler IA, Persing DH (2012) Antimicrobial-resistant strains of Clostridium difficile from North America. Antimicrob Agents Chemother 56:2929–2932

    Article  PubMed  CAS  Google Scholar 

  • Uttley AH, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J (1989) High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 103:173–181

    Article  PubMed  CAS  Google Scholar 

  • Valsesia G, Rossi M, Bertschy S, Pfyffer GE (2010) Emergence of SCCmec type IV and SCCmec type V methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leukocidin genes in a large academic teaching hospital in central Switzerland: external invaders or persisting circulators? J Clin Microbiol 48:720–727

    Article  PubMed  CAS  Google Scholar 

  • van Cleef BA, Monnet DL, Voss A, Krziwanek K, Allerberger F, Struelens M, Zemlickova H, Skov RL, Vuopio-Varkila J, Cuny C, Friedrich AW, Spiliopoulou I, Pászti J, Hardardottir H, Rossney A, Pan A, Pantosti A, Borg M, Grundmann H, Mueller-Premru M, Olsson-Liljequist B, Widmer A, Harbarth S, Schweiger A, Unal S, Kluytmans JA (2011) Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis 17:502–505

    Article  PubMed  Google Scholar 

  • van der Mee-Marquet N, Francois P, Domelier-Valentin AS, Coulomb F, Decreux C, Hombrock-Allet C, Lehiani O, Neveu C, Ratovohery D, Schrenzel J, Quentin R (2011) Emergence of unusual bloodstream infections associated with pig-borne-like Staphylococcus aureus ST398 in France. Clin Infect Dis 52:152–153

    Article  PubMed  Google Scholar 

  • Wassenberg MW, Bootsma MC, Troelstra A, Kluytmans JA, Bonten MJ (2011) Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus (ST398) in Dutch hospitals. Clin Microbiol Infect 17:316–319

    Article  PubMed  CAS  Google Scholar 

  • Welte T, Pletz MW (2010) Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. Int J Antimicrob Agents 36:391–400

    Article  PubMed  CAS  Google Scholar 

  • Werner G, Gfrorer S, Fleige C, Witte W, Klare I (2008) Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother 61:1182–1183

    Article  PubMed  CAS  Google Scholar 

  • Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJ (2005) Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11:821–828

    Google Scholar 

  • Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J (2012) Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 54:621–629

    Article  PubMed  CAS  Google Scholar 

  • Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, Zhu D, Hu F, Zhang Y, Wang F, Jacoby GA, Wang M (2010) vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother 54:4643–4647

    Article  PubMed  CAS  Google Scholar 

  • Yang SJ, Kreiswirth BN, Sakoulas G, Yeaman MR, Xiong YQ, Sawa A, Bayer AS (2009) Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus. J Infect Dis 200:1916–1920

    Article  PubMed  CAS  Google Scholar 

  • Yang SJ, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS (2010) Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms. Antimicrob Agents Chemother 54:3079–3085

    Article  PubMed  CAS  Google Scholar 

  • Zhanel GG, Calic D, Schweizer F, Zelenitsky S, Adam H, Lagace-Wiens PR, Rubinstein E, Gin AS, Hoban DJ, Karlowsky JA (2010) New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin. Drugs 70:859–886

    Article  PubMed  CAS  Google Scholar 

  • Zhao C, Sun H, Wang H, Liu Y, Hu B, Yu Y, Sun Z, Chu Y, Cao B, Liao K, Lei J, Hu Z, Zhang L, Zhang X, Xu Y, Wang Z, Chen M (2012) Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-positive cocci resistance surveillance program (2005–2010). Diagn Microbiol Infect Dis 73:174–181

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Biotechnologies, University of Siena, Siena, Italy

    Gian Maria Rossolini, Fabio Arena & Simona Pollini

  2. Department of Experimental and Clinical Medicine, Section of Critical Care and Specialistic Medicines, University of Florence, Florence, Italy

    Gian Maria Rossolini

  3. Department of Laboratory Medicine, Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy

    Gian Maria Rossolini

Authors
  1. Gian Maria Rossolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabio Arena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Simona Pollini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gian Maria Rossolini .

Editor information

Editors and Affiliations

  1. Dipartimento di Biotecnologie e Scienze Molecolari, Università degli Studi dell'Insubria, Varese, Italy

    Flavia Marinelli

  2. Parque Tecnológico Ciencias de la Salud, Fundación MEDINA, Granada, Spain

    Olga Genilloud

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rossolini, G.M., Arena, F., Pollini, S. (2014). Novel Infectious Diseases and Emerging Gram-Positive Multi-Resistant Pathogens in Hospital and Community Acquired Infections. In: Marinelli, F., Genilloud, O. (eds) Antimicrobials. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39968-8_2

Download citation

Publish with us

Policies and ethics

Search

Navigation